1. |
Chakravarthy U, Williams M. The royal college of ophthalmologists guidelines on AMD: executive summary[J]. Eye (Lond), 2013, 27(12): 1429-1431. DOI: 10.1038/eye.2013.233.
|
2. |
邹洪强, 田洪芹, 张艳平, 等. 阿柏西普治疗眼底血管性疾病的临床研究新进展[J]. 眼科新进展, 2017, 37(9): 894-897. DOI: 10.13389/j.cnki.rao.2017.0227.Zou HQ, Tian HQ, Zhang YP, et al. Recent advances in clinical research on aflibercept treating fundus vascular diseases[J]. Rec Adv Ophthalmol, 2017, 37(9): 894-897. DOI: 10.13389/j.cnki.rao.2017.0227.
|
3. |
Carrasco J, Pietsch GA, Nicolas MP, et al. Real-world effectiveness and real-world cost-effectiveness of intravitreal aflibercept and intravitreal ranibizumab in neovascular age-related macular degeneration: systematic review and meta-analysis of real-world studies[J]. Adv Ther, 2020, 37(1): 300-315. DOI: 10.1007/s12325-019-01147-6.
|
4. |
Au A, Parikh VS, Singh RP, et al. Comparison of anti-VEGF therapies on fibrovascular pigment epithelial detachments in age-related macular degeneration[J]. Br J Ophthalmol, 2017, 101(7): 970-975. DOI: 10.1136/bjophthalmol-2016-309434.
|
5. |
Waldstein SM, Simader C, Staurenghi G, et al. Morphology and visual acuity in aflibercept and ranibizumab therapy for neovascular age-related macular degeneration in the VIEW trials[J]. Ophthalmology, 2016, 123(7): 1521-1529. DOI: 10.1016/j.ophtha.2016.03.037.
|
6. |
Dirani A, Ambresin A, Marchionno L, et al. Factors influencing the treatment response of pigment epithelium detachment in age-related macular degeneration[J]. Am J Ophthalmol, 2015, 160(4): 732-738. DOI: 10.1016/j.ajo.2015.06.025.
|
7. |
de Massougnes S, Dirani A, Mantel I. Good visual outcome at 1 year in neovascular age-related macular degeneration with pigment epithelium detachment: factors influencing the treatment response[J]. Retina, 2018, 38(4): 717-724. DOI: 10.1097/IAE.0000000000001613.
|
8. |
Amoaku WM, Chakravarthy U, Gale R, et al. Defining response to anti-VEGF therapies in neovascular AMD[J]. Eye (Lond), 2015, 29(10): 1397-1398. DOI: 10.1038/eye.2015.159.
|
9. |
Diaconita V, Li B, Pal L, et al. Prospective evaluation of aflibercept in pigment epithelial detachments secondary to neovascular age related macular degeneration[J]. Can J Ophthalmol, 2019, 54(5): 626-634. DOI: 10.1016/j.jcjo.2019.01.004.
|
10. |
Simader C, Ritter M, Bolz M, et al. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration[J]. Ophthalmology, 2014, 121(6): 1237-1245. DOI: 10.1016/j.ophtha.2013.12.029.
|
11. |
杨诚, 于珊珊, 周焕娇, 等. 抗血管内皮生长因子单克隆抗体bevacizumab治疗渗出型老年性黄斑变性疗效观察及无效病例分析[J]. 中华眼底病杂志, 2011, 27(6): 529-533. DOI: 10.3760/cma.j.issn.1005-1015.2011.06.007.Yang C, Yu SS, Zhou HJ, et al. Therapeutic effects of intravitreal injection of bevacizumab on age-related macular degeneration and non-responders analysis[J]. Chin J Ocul Fundus Dis, 2011, 27(6): 529-533. DOI: 10.3760/cma.j.issn.1005-1015.2011.06.007.
|
12. |
Nguyen V, Daien V, Guymer R, et al. Projection of long-term visual acuity outcomes based on initial treatment response in neovascular age-related macular degeneration[J]. Ophthalmology, 2019, 126(1): 64-74. DOI: 10.1016/j.ophtha.2018.08.023.
|
13. |
赵莼, 王方, 陈磊, 等. 玻璃体腔注射雷珠单抗治疗渗出型老年性黄斑变性伴浆液性视网膜色素上皮脱离的疗效观察[J]. 中华眼底病杂志, 2015, 31(1): 27-30. DOI: 10.3760/cma.j.issn.1005-1015.2015.01.008.Zhao C, Wang F, Chen L, et al. Effect of ranibizumab on serous pigment epithelial detachments associated with wet age-related macular degeneration[J]. Chin J Ocul Fundus Dis, 2015, 31(1): 27-30. DOI: 10.3760/cma.j.issn.1005-1015.2015.01.008.
|
14. |
马楠, 陈有信. 息肉样脉络膜血管病变伴视网膜色素上皮撕裂的临床特征[J]. 中华眼底病杂志, 2015, 31(4): 387-388. DOI: 10.3760/cma.j.issn.1005-1015.2015.04.020.Ma N, Chen YX. Clinical characteristics of polypoidal choroidal vasculopathy with retinal pigment epithelial tear[J]. Chin J Ocul Fundus Dis, 2015, 31(4): 387-388. DOI: 10.3760/cma.j.issn.1005-1015.2015.04.020.
|
15. |
Sato T, Ooto S, Suzuki M, et al. Retinal pigment epithelial tear after intravitreal aflibercept for neovascular age-related macular degeneration[J]. Ophthalmic Surg Lasers Imaging Retina, 2015, 46(1): 87-90. DOI: 10.3928/23258160-20150101-16.
|
16. |
Cunningham EJ, Feiner L, Chung C, et al. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration[J]. Ophthalmology, 2011, 118(12): 2447-2452. DOI: 10.1016/j.ophtha.2011.05.026.
|
17. |
Fujii A, Imai H, Kanai M, et al. Effect of intravitreal aflibercept injection for age-related macular degeneration with a retinal pigment epithelial tear refractory to intravitreal ranibizumab injection[J]. Clin Ophthalmol, 2014, 8: 1199-1202. DOI: 10.2147/OPTH.S65810.
|